Eckert & Ziegler Strahlen- und Medizintechnik AG

Earnings Release • May 8, 2007

News Details

Corporate | 8 May 2007 07:45

Eckert & Ziegler increases earnings by 17%

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Quarter Results

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, 8 May 2007. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN
DE0005659700), a specialist for cancer radiation and radiometric systems,
posted a surplus after taxes and minority distributions of 760,000 EUR or
0.24 EUR per share, representing an increase of 17% over last year's figure
of 650,000 EUR (0.21 EUR per share). Overall group sales rose by 15% to 13
million EUR.

As in previous quarters and in spite of a recently unfavorable US dollar
exchange rate development, the most profitable area was the Nuclear
Medicine and Imaging segment, which contributed 560,000 EUR to the total
surplus (last year: 360,000 EUR). The Therapy segment raised its earnings
from 160,000 to 350,000 EUR, while the Radiopharmaceuticals segment, which
is currently under development, posted a loss of 160,000 EUR. Sales in the
Therapy segment represented an especially strong growth factor, benefiting
from a large-scale contract for tumor radiation systems and rising volumes
of prostate implants.

For the current business year, the Board anticipates sales of around 55
million EUR and profits of 2.8 million EUR (0.90 EUR per share).

Eckert & Ziegler is a globally active specialist for radiation applications
in medicine, science and industry. Its main areas of activity are cancer
therapy, nuclear medical diagnostics, and measurement technology. Listed on
the Frankfurt Prime Standard (ISIN DE0005659700), the Group is
headquartered in Berlin-Buch and has more than 300 employees. In addition
to seven German sites, it has branch offices in Los Angeles, Atlanta, San
Francisco, Prague, Paris, Milan, and Chennai (India).

Your contact:
Eckert & Ziegler AG
Karolin Riehle / Thomas Scheuch, Investor Relations, Robert-Rössle-Str. 10,
D-13125 Berlin
phone: +49 (0) 30 / 94 10 84-138; fax –112; e-mail: karolin.riehle@ezag.de,
www.ezag.de

DGAP 08.05.2007

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
www: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices:
Listed: Geregelter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin-Bremen, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---